Paracetamol Plus Tramadol Versus Fentanyl in Day Case Surgeries
1 other identifier
interventional
102
1 country
1
Brief Summary
Postoperative pain is an important problem, especially for day case surgeries. It has negative effects on patient's hemodynamics and can cause delayed ambulation resulting in prolonged duration of hospital stay and poor patient satisfaction. Multiple analgesic strategies have been proposed including NSAID, opioids, epidural analgesia. Each of them has its limitations. In this study the investigators will compare the effect of preemptive use of paracetamol plus tramadol versus preemptive intravenous fentanyl in controlling postoperative pain
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Jun 2025
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedStudy Start
First participant enrolled
June 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedSeptember 15, 2026
September 1, 2026
7 months
July 29, 2023
September 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Enhanced Recovery Score
It will be derived from the 40-item Quality of Recovery questionnaire (QoR-40), which assesses five dimensions of postoperative recovery: emotional state, physical comfort, psychological support, physical independence and pain. Each of the 40 items is scored from 1 (worst) to 5 (best), yielding a total score ranging from 40 to 200.
The QoR-40 was administered 24 hours after the surgery by an anaesthesiologist independent of the anaesthetic team and not involved in drug administration.
Secondary Outcomes (5)
Postoperative pain intensity
On arrival to the recovery room and at 1, 2, 4, 6, and 12 hours postoperatively.
Rescue analgesic
From arrival to the recovery room until the first request for rescue analgesia, assessed up to 24 hours postoperatively.
Postoperative sedation/agitation
After extubation, on arrival to the recovery room and at 10 and 20 minutes after arrival to the recovery room.
Mean arterial blood pressure
Baseline (preoperatively) and on arrival to the recovery room postoperatively.
Heart Rate
Baseline (preoperatively) and on arrival to the recovery room postoperatively.
Other Outcomes (2)
Adverse events
Up to twenty-four hours after surgery
Length of hospital stay
Up to twenty-four hours after surgery.
Study Arms (2)
Paracetamol plus tramadol
ACTIVE COMPARATORPatients in Group T received an intravenous infusion of paracetamol (15 mg/kg) with tramadol (1 mg/kg), completed immediately before induction of anaesthesia.
Fentanyl
ACTIVE COMPARATORGroup F received a single intravenous injection of fentanyl 1.5 µg/kg before induction.
Interventions
Group F received a single intravenous injection of fentanyl 1.5 µg/kg before induction.
Patients in Group T received an intravenous infusion of paracetamol (15 mg/kg) with tramadol (1 mg/kg), completed immediately before induction of anaesthesia.
Eligibility Criteria
You may qualify if:
- Patients scheduled for day case surgeries.
- Patient's age: 21-65 years.
- Patients with ASA physical status I, II.
- BMI 25 - 30 25-30 kg/m²
You may not qualify if:
- Uncooperative patients
- Patients with psychological problems
- Patients with liver or renal impairment
- Patients with a history of allergy to the drugs used in the study
- Patients with chronic pain and current use of analgesic therapy for a pre-existing condition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Zagazig University , Fuculty of Medicine
Zagazig, Sharquia, 7120730, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
MICHAEL A shaker, lecturer
Zagazig University
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Patients were blinded to their allocated group. The anaesthesiologist who assessed postoperative VAS and sedation scores and who administered rescue analgesia, antiemetics, or treatment for hypotension and bradycardia was also blinded to group allocation. Only the anaesthetic team in the operating theatre, who administered the study drugs and general anaesthesia, was aware of the allocated group, owing to differences in the volume and appearance of the two regimens.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of anesthesia and intensive care
Study Record Dates
First Submitted
July 29, 2023
First Posted
August 14, 2023
Study Start
June 1, 2025
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
September 15, 2026
Record last verified: 2026-09